FORT MYERS, Fla., Feb. 28, 2025 /PRNewswire/ — Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that board-certified medical oncologist and hematologist Raju Vaddepally, MD has joined its team of cancer experts in Collier County. He is providing care to patients at FCS Naples Napa Ridge, 3530 Kraft Road, Suite 300, Naples, Florida 34105-5020 and at FCS Naples Goodlette, 1100 Goodlette-Frank Rd. N., Naples, FL 34102-5451.
“Collier County is one of the fast growing communities in Florida,” noted FCS Assistant Managing Physician David Wenk, MD. “As we have for more than 40 years, FCS continues to provide what is needed to ensure that patients have convenient access to world-class cancer care close to home. With Dr. Vaddepally’s impressive credentials, which include a lead role in cancer treatment advancements, FCS is well equipped to deliver comprehensive care and therapies so that local residents achieve the most positive outcomes.”
Actively involved in community-based cancer research, Dr. Vaddepally has a specialized focus on thoracic, head and neck, and skin cancers. After receiving his medical degree from Osmania Medical College in Hyderabad, India, Dr. Vaddepally completed internal medicine residency training at Trinity Health Ann Harbor Hospital in Ypsilanti, Michigan and a fellowship in oncology/hematology at Henry Ford Medical Center in Detroit.
FCS Chief Executive Officer Nathan H. Walcker said, “Dr. Vaddepally’s commitment to serving his patients with a compassionate and holistic approach personalized for their individual needs aligns with our mission and values. We are delighted to welcome him to our statewide practice.”
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its robust clinical research program.
FCS provides patients with access to a wide range of clinical trials, positioning it as a leader in research among private oncology practices in Florida and across the country. In fact, before receiving FDA approval, the majority of new cancer drugs in the U.S. were first made available to patients through participation in clinical trials at FCS.
Our outstanding team of highly trained and dedicated physicians is committed to delivering tailored treatment plans that make the best use of cutting-edge precision oncology advancements to enhance patient outcomes.
SOURCE Florida Cancer Specialists & Research Institute
